Reaction Biology Corp., Synerga Limited (2013) Selective kinase inhibitors. .
Full text not currently available from Enlighten.
Publisher's URL: http://www.google.com/patents/US8592415
Abstract
The present invention relates to methods of modulating (for example, inhibiting) activity of JAK3, comprising contacting the JAK3 with a compound of Formula I or pharmaceutically acceptable salt thereof, wherein constituent members are provided hereinwith. The present invention further provides novel compounds and compositions as well as their methods of preparation and use of the same as JAK3 inhibitors in the treatment of JAK3-associated diseases including, for example, inflammatory and autoimmune disorders.
| Item Type: | Patents |
|---|---|
| Additional Information: | Part of PAT: US 8592415 B2. |
| Status: | Published |
| Glasgow Author(s) Enlighten ID: | Dietrich, Bart |
| Authors: | Ma, H., Filip, S. V., Henry, M. A., Dolan, J. A., and Dietrich, B. |
| College/School: | College of Science and Engineering > School of Chemistry |
| First Published: | 26 November 2013 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details